Prot #R668-AD-1652: A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Dupilumab Administered Concomitantly with Topical Corticosteroids in Patients, ≥6 Years to <12 Years of Age, with Severe Atopic Dermatitis